Education
About Us
Working with TipRanks
Follow Us
Universal Health (UHS)
NYSE:UHS
UHS Analyst Ratings
Moderate Buy
6 Buy
6 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
UHS Stock 12 Month Forecast
Average Price Target
$229.09
▲(28.64%Upside)
| Highest Price Target$280.00 | Average Price Target$229.09 | Lowest Price Target$200.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$190
Hold
6.69%
Upside
Downgraded
06/10/25
Universal Health Services presents a mixed investment outlook. The most significant strengths include strong financial performance and promising earnings growth. However, technical analysis signals a bearish trend, and uncertainties around Medicaid payments and cash flows present risks. The valuation appears favorable with low P/E, but dividend yield is modest.
Barclays
$257
Buy
44.32%
Upside
Reiterated
06/24/25
Leerink Partners
$252→$253
Buy
42.07%
Upside
Reiterated
06/17/25
Morgan Stanley
$200
Hold
12.31%
Upside
Reiterated
06/04/25
Wells Fargo
$225
Buy
26.35%
Upside
Reiterated
05/29/25
Cantor Fitzgerald
$227
Hold
27.47%
Upside
Reiterated
05/28/25
RBC Capital
$211→$201
Hold
12.87%
Upside
Reiterated
04/30/25
KeyBanc
―
Hold
―
Reiterated
04/30/25
Guggenheim
$208→$212
Buy
19.05%
Upside
Reiterated
04/30/25
Bank of America Securities
$215
Hold
20.73%
Upside
Reiterated
04/29/25
TD Cowen
$226
Buy
26.91%
Upside
Reiterated
04/29/25
Robert W. Baird
$274→$224
Hold
25.79%
Upside
Downgraded
04/14/25
J.P. Morgan
$215
Hold
20.73%
Upside
Reiterated
03/14/25
Stephens
$223
Hold
25.22%
Upside
Reiterated
02/27/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$190
Hold
6.69%
Upside
Downgraded
06/10/25
Universal Health Services presents a mixed investment outlook. The most significant strengths include strong financial performance and promising earnings growth. However, technical analysis signals a bearish trend, and uncertainties around Medicaid payments and cash flows present risks. The valuation appears favorable with low P/E, but dividend yield is modest.
Barclays
$257
Buy
44.32%
Upside
Reiterated
06/24/25
Leerink Partners
$252→$253
Buy
42.07%
Upside
Reiterated
06/17/25
Morgan Stanley
$200
Hold
12.31%
Upside
Reiterated
06/04/25
Wells Fargo
$225
Buy
26.35%
Upside
Reiterated
05/29/25
Cantor Fitzgerald
$227
Hold
27.47%
Upside
Reiterated
05/28/25
RBC Capital
$211→$201
Hold
12.87%
Upside
Reiterated
04/30/25
KeyBanc
―
Hold
―
Reiterated
04/30/25
Guggenheim
$208→$212
Buy
19.05%
Upside
Reiterated
04/30/25
Bank of America Securities
$215
Hold
20.73%
Upside
Reiterated
04/29/25
TD Cowen
$226
Buy
26.91%
Upside
Reiterated
04/29/25
Robert W. Baird
$274→$224
Hold
25.79%
Upside
Downgraded
04/14/25
J.P. Morgan
$215
Hold
20.73%
Upside
Reiterated
03/14/25
Stephens
$223
Hold
25.22%
Upside
Reiterated
02/27/25
Best Analysts Covering Universal Health
1 Month
xxx
Success Rate
17/23 ratings generated profit
Average Return
+1.40%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 73.91% of your transactions generating a profit, with an average return of +1.40% per trade.
3 Months
xxx
Success Rate
19/27 ratings generated profit
Average Return
+2.81%
reiterated a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 70.37% of your transactions generating a profit, with an average return of +2.81% per trade.
1 Year
2 Years
xxx
Success Rate
20/29 ratings generated profit
Average Return
+20.32%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 68.97% of your transactions generating a profit, with an average return of +20.32% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
UHS Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
0
0
0
0
1
Buy
5
6
12
10
12
Hold
6
6
13
11
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
12
25
21
22
Each month's total comprises the sum of three months' worth of ratings.
UHS Financial Forecast
UHS Stock Forecast FAQ
What is UHS’s average 12-month price target, according to analysts?
Based on analyst ratings, Universal Health’s 12-month average price target is 229.09.
What is UHS’s upside potential, based on the analysts’ average price target?
Universal Health has 28.64% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is UHS a Buy, Sell or Hold?
Universal Health has a consensus rating of Moderate Buy which is based on 6 buy ratings, 6 hold ratings and 0 sell ratings.
What is Universal Health’s price target?
The average price target for Universal Health is 229.09. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $280.00 ,the lowest forecast is $200.00. The average price target represents 28.64% Increase from the current price of $178.08.
The highest analyst price target is $280.00 ,the lowest forecast is $200.00. The average price target represents 28.64% Increase from the current price of $178.08.
What do analysts say about Universal Health?
Universal Health’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of UHS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.